EMPOWER PHARMACY
Live / Applied — Suspended — suspension check completed, case still suspended (as of 08 Sept 2025)
What this means for you
Not registered yet, but its 14 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98601554
- Mark type
- Stylized text
- Filed
- 14 Jun 2024
- Attorney of record
- John A. Yates
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for weight management, hormone replacement therapy, intravenous therapy, intravenous nutrition, injectable therapy, dietary nutrition, mental health, skin care, sexual dysfunction, fertility, men's health, and women's health; pharmaceutical preparations for the prevention, reduction, and treatment of cardiovascular, lymphatic, respiratory, pulmonary, neurological, renal, gastrointestinal, musculoskeletal, dermatological, allergic, inflammatory, autoimmune, gynecological, genetic, longevity, metabolic, and pain conditions; disinfecting wipes; and sanitizing wipes
- Class 010 — Medical apparatus: Medical syringes; disposable syringes; syringe barrels; luer lock syringe barrels; injection needles for medical use; vial adapters for syringes; trocars; and containers adapted for the disposal of medical instruments and syringes
Owner
- Empower Clinic Services, L.L.C., Houston, TX, US
Prosecution history
- 08 Sept 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 07 Mar 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 07 Mar 2025 — LETTER OF SUSPENSION E-MAILED
- 07 Mar 2025 — SUSPENSION LETTER WRITTEN
- 14 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Nov 2024 — NON-FINAL ACTION E-MAILED
- 13 Nov 2024 — NON-FINAL ACTION WRITTEN
- 06 Nov 2024 — ASSIGNED TO EXAMINER
- 14 Jun 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Jun 2024 — NEW APPLICATION ENTERED